{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:59:05Z","timestamp":1777561145933,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005363","name":"University of Buenos Aires","doi-asserted-by":"publisher","award":["UBACyT CB23"],"award-info":[{"award-number":["UBACyT CB23"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["CONICET PIP 516"],"award-info":[{"award-number":["CONICET PIP 516"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["ANPCyT 0418"],"award-info":[{"award-number":["ANPCyT 0418"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.atherosclerosis.2016.06.009","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T10:40:05Z","timestamp":1465900805000},"page":"438-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Associations between disease activity, markers of HDL functionality and arterial stiffness in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"251","author":[{"given":"Eliana","family":"Botta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2673-3494","authenticated-orcid":false,"given":"Tom\u00e1s","family":"Mero\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Saucedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximiliano","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Tetzlaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Sorroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Boero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Malah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Menafra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4196-2391","authenticated-orcid":false,"given":"Leonardo","family":"G\u00f3mez Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatol","family":"Kontush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Brites","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib2","first-page":"36","article-title":"Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis","volume":"30","author":"Wolfe","year":"2003","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/ard.2004.034777","article-title":"Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s","volume":"64","author":"Goodson","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib4","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rincon","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11882-014-0497-6","article-title":"Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?","volume":"15","author":"Bag-Ozbek","year":"2015","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib6","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/rheumatology\/keu224","article-title":"Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment","volume":"53","author":"Choy","year":"2014","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib8","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2796.2006.01647.x","article-title":"The rationale for using apoA-I as a clinical marker of cardiovascular risk","volume":"259","author":"Barter","year":"2006","journal-title":"J.\u00a0Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib10","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","author":"Aviram","year":"1998","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cbf.1257","article-title":"Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis","volume":"24","author":"Baskol","year":"2006","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib12","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/S0024-3205(03)00195-4","article-title":"Serum paraoxonase activity decreases in rheumatoid arthritis","volume":"72","author":"Tanimoto","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib13","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/ard.2008.092171","article-title":"Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients","volume":"68","author":"Popa","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib14","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/eurheartj\/ehu105","article-title":"The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial","volume":"35","author":"Ray","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2007.08.009","article-title":"Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity","volume":"197","author":"de Souza","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00125-004-1655-5","article-title":"Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia","volume":"48","author":"Nobecourt","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/07853890.2015.1068950","article-title":"Non-invasive assessment of arterial stiffness in patients with rheumatoid arthritis: a systematic review and meta-analysis of literature studies","volume":"47","author":"Ambrosino","year":"2015","journal-title":"Ann. Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/03009742.2013.836564","article-title":"Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress","volume":"43","author":"Lo Gullo","year":"2014","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib19","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/CIRCULATIONAHA.112.120410","article-title":"Anti-tumor necrosis factor-alpha therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis","volume":"126","author":"Maki-Petaja","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3899\/jrheum.100689","article-title":"Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year followup study of 108 patients with rheumatoid arthritis","volume":"38","author":"Provan","year":"2011","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib21","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acr.21649","article-title":"Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice","volume":"64","author":"Anderson","year":"2012","journal-title":"Arthritis Care Res. Hob."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/01.ATV.13.6.815","article-title":"Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects","volume":"13","author":"Lagrost","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0003-2697(89)90424-7","article-title":"Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase\/arylesterase","volume":"180","author":"Furlong","year":"1989","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib25","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.ATV.16.10.1243","article-title":"Paraoxonase genotypes, lipoprotein lipase activity, and HDL","volume":"16","author":"Nevin","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00004872-200104000-00019","article-title":"Pulse wave velocity as endpoint in large-scale intervention trial. The complior study. Scientific, quality control, coordination and investigation Committees of the complior study","volume":"19","author":"Asmar","year":"2001","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.HYP.26.3.485","article-title":"Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies","volume":"26","author":"Asmar","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10067-006-0300-8","article-title":"Paraoxonase and arylesterase levels in rheumatoid arthritis","volume":"26","author":"Isik","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.clinbiochem.2005.06.010","article-title":"Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis","volume":"38","author":"Baskol","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10067-009-1118-y","article-title":"A\u00a0comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases","volume":"28","author":"Soltesz","year":"2009","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jjcc.2011.09.004","article-title":"Evaluation of pulse wave velocity in systemic lupus erythematosus, rheumatoid arthritis and Behcet\u2019s disease","volume":"59","author":"Kocabay","year":"2012","journal-title":"J.\u00a0Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10067-015-2914-1","article-title":"Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors","volume":"34","author":"Arida","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib33","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1074\/jbc.273.11.6080","article-title":"Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol","volume":"273","author":"Garner","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib34","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.1074\/jbc.273.11.6088","article-title":"Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII","volume":"273","author":"Garner","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11745-013-3779-1","article-title":"Plasma HDL reduces nonesterified fatty acid hydroperoxides originating from oxidized LDL: a mechanism for its antioxidant ability","volume":"48","author":"Kotosai","year":"2013","journal-title":"Lipids"},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib36","doi-asserted-by":"crossref","first-page":"H219","DOI":"10.1152\/ajpheart.00850.2012","article-title":"Apolipoprotein A-1 mimetic D-4F enhances isoflurane-induced eNOS signaling and cardioprotection during acute hyperglycemia","volume":"305","author":"Baotic","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2014.02.026","article-title":"The HDL anti-inflammatory function is impaired in myocardial infarction and may predict new cardiac events independent of HDL cholesterol","volume":"433","author":"Dullaart","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib38","article-title":"The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis","volume":"4","author":"Liao","year":"2015","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/978-3-319-09665-0_14","article-title":"Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions","volume":"224","author":"Montecucco","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib40","doi-asserted-by":"crossref","first-page":"607924","DOI":"10.1155\/2014\/607924","article-title":"Markers of systemic inflammation and Apo-AI containing HDL subpopulations in women with and without diabetes","volume":"2014","author":"Russo","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.mol.0000174398.84185.0f","article-title":"Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences","volume":"16","author":"Aviram","year":"2005","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2015.06.004","article-title":"Paraoxonase-1 and oxidized lipoprotein lipids. The cardiovascular risk in Young Finns study","volume":"241","author":"Kresanov","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib43","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/ATVBAHA.109.194555","article-title":"HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis","volume":"29","author":"Zerrad-Saadi","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","article-title":"Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles","volume":"567","author":"Mackness","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib45","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3892\/mmr.2014.2804","article-title":"Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis","volume":"11","author":"Shen","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.atherosclerosis.2014.09.034","article-title":"Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation","volume":"237","author":"Rosso","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2015.12.021","article-title":"Serum paraoxonase-1 activity and risk of incident cardiovascular disease: the PREVEND study and meta-analysis of prospective population studies","volume":"245","author":"Kunutsor","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1074\/jbc.270.1.189","article-title":"The influence of cholesteryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins","volume":"270","author":"Rye","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0009-9120(03)00078-X","article-title":"Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity","volume":"36","author":"Rashid","year":"2003","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib50","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3899\/jrheum.121507","article-title":"Cholesteryl ester transfer protein in patients with rheumatoid arthritis","volume":"40","author":"Ferraz-Amaro","year":"2013","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib51","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar1952","article-title":"Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment\u2013a prospective, controlled study","volume":"8","author":"Georgiadis","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.06.009_bib52","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2362.2008.01994.x","article-title":"High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy","volume":"38","author":"Garcia-Gomez","year":"2008","journal-title":"Eur. J. Clin. Investig."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016302544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016302544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T10:48:48Z","timestamp":1655981328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016302544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":52,"alternative-id":["S0021915016302544"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.06.009","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between disease activity, markers of HDL functionality and arterial stiffness in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}